Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Murray Hill, New Jersey 07974


Purpose:

The primary objective of this study is to assess the efficacy and safety of 2 concentrations of RX-10045 ophthalmic solution, 0.05% and 0.1%, compared to placebo for the treatment of ocular inflammation and pain in subjects undergoing cataract surgery.


Criteria:

Inclusion Criteria: - Unilateral cataract surgery (phacoemulsification or extracapsular extraction) with posterior chamber intraocular lens implantation in the capsular bag. Exclusion Criteria: - Any additional surgical procedures at the time of the cataract surgery - Refractive surgery in the study eye within the past 2 years - History or presence of noninfectious inflammatory ocular disease (e.g., episcleritis, scleritis, uveitis) in either eye - Intraocular pressure of > 21 mm Hg in either eye - Proliferative or severe nonproliferative diabetic retinopathy in either eye - Neovascular/wet age-related macular degeneration in either eye


NCT ID:

NCT02329743


Primary Contact:

Study Director
Tomasz Sablinski, MD
Auven Therapeutics


Backup Contact:

N/A


Location Contact:

Murray Hill, New Jersey 07974
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 21, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.